Skip to main content

and
  1. No Access

    Article

    AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3

    M Wunderlich, F-S Chou, K A Link, B Mizukawa, R L Perry, M Carroll, J C Mulloy in Leukemia (2010)

  2. No Access

    Article

    Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs

    The AML1-ETO fusion protein, which is present in 10–15% of cases of acute myeloid leukemia, is known to repress myeloid differentiation genes through DNA binding and recruitment of chromatin-modifying proteins...

    A Maiques-Diaz, F S Chou, M Wunderlich, G Gómez-López, F V Jacinto in Leukemia (2012)